4-((3,5-Dibromo-2-hydroxybenzylidene)amino)-3-(pyridin-2-yl)-1H-1,2,4-triazole-5(4H)-thione

Catalog No. :
ACSGGT547
CAS No. :
613248-46-7
Molecular Formula :
C14H9Br2N5OS
Molecular Weight :
455.14

IUPAC Name:(E)-4-((3,5-dibromo-2-hydroxybenzylidene)amino)-5-(pyridin-2-yl)-2,4-dihydro-3H-1,2,4-triazole-3-thione

4-((3,5-Dibromo-2-hydroxybenzylidene)amino)-3-(pyridin-2-yl)-1H-1,2,4-triazole-5(4H)-thione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-((3,5-Dibromo-2-hydroxybenzylidene)amino)-3-(pyridin-2-yl)-1H-1,2,4-triazole-5(4H)-thione
IUPAC Name(E)-4-((3,5-dibromo-2-hydroxybenzylidene)amino)-5-(pyridin-2-yl)-2,4-dihydro-3H-1,2,4-triazole-3-thione
MDL No.MFCD03675016
Molecular FormulaC14H9Br2N5OS
Molecular Weight455.14
SMILESS=C1NN=C(C2=NC=CC=C2)N1/N=C/C3=CC(Br)=CC(Br)=C3O
InChI KeyPZEXTXZCSNSBGZ-CNHKJKLMSA-N
SynonymSALOR-INT L468142-1EA;2,4-DIBROMO-6-(((3-MERCAPTO-5-(2-PYRIDINYL)4H-1,2,4-TRIAZOL-4-YL)IMINO)ME)PHENOL;(E)-2,4-dibromo-6-(((3-mercapto-5-(pyridin-2-yl)-4H-1,2,4-triazol-4-yl)imino)methyl)phenol
CAS No.613248-46-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACSGGT547 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSGGT547 route product structure diagram
    ACSGGT547613248-46-7
Inquiry

2. ACSGGT547 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSGGT547 route product structure diagram
    ACSGGT547613248-46-7
Inquiry

Comments (0)